1. Home
  2. FATE vs INSG Comparison

FATE vs INSG Comparison

Compare FATE & INSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • INSG
  • Stock Information
  • Founded
  • FATE 2007
  • INSG 1996
  • Country
  • FATE United States
  • INSG United States
  • Employees
  • FATE N/A
  • INSG N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • INSG Telecommunications Equipment
  • Sector
  • FATE Health Care
  • INSG Telecommunications
  • Exchange
  • FATE Nasdaq
  • INSG Nasdaq
  • Market Cap
  • FATE 108.2M
  • INSG 111.5M
  • IPO Year
  • FATE 2013
  • INSG 2000
  • Fundamental
  • Price
  • FATE $1.28
  • INSG $8.32
  • Analyst Decision
  • FATE Hold
  • INSG Buy
  • Analyst Count
  • FATE 8
  • INSG 3
  • Target Price
  • FATE $5.43
  • INSG $13.00
  • AVG Volume (30 Days)
  • FATE 2.5M
  • INSG 107.3K
  • Earning Date
  • FATE 05-08-2025
  • INSG 05-08-2025
  • Dividend Yield
  • FATE N/A
  • INSG N/A
  • EPS Growth
  • FATE N/A
  • INSG N/A
  • EPS
  • FATE N/A
  • INSG 0.10
  • Revenue
  • FATE $13,631,000.00
  • INSG $191,244,000.00
  • Revenue This Year
  • FATE N/A
  • INSG $2.53
  • Revenue Next Year
  • FATE N/A
  • INSG $11.55
  • P/E Ratio
  • FATE N/A
  • INSG $95.82
  • Revenue Growth
  • FATE N/A
  • INSG 14.32
  • 52 Week Low
  • FATE $0.66
  • INSG $3.00
  • 52 Week High
  • FATE $5.92
  • INSG $20.67
  • Technical
  • Relative Strength Index (RSI)
  • FATE 60.93
  • INSG 52.02
  • Support Level
  • FATE $1.02
  • INSG $6.80
  • Resistance Level
  • FATE $1.49
  • INSG $8.54
  • Average True Range (ATR)
  • FATE 0.17
  • INSG 0.56
  • MACD
  • FATE 0.05
  • INSG 0.23
  • Stochastic Oscillator
  • FATE 74.07
  • INSG 90.43

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About INSG Inseego Corp.

Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).

Share on Social Networks: